November 17, 2021 – Together with the Food Allergy Fund, Johnson & Johnson Innovation and the Healthy Baby Initiative within Janssen Research & Development’s World Without Disease Accelerator (WWDA) are proud to launch the Food Allergy Prevention QuickFire Challenge with the aim to identify potential solutions to prevent children from developing food allergy in the early years of their life.

Food allergy is a growing public health problem. For many affected individuals, food allergy begins early in life and persists as a lifelong condition. Research suggests there is a window of opportunity in the early years of a child’s life to reduce the risk of food allergy with early and ongoing ingestion of allergenic foods such as peanut and a diverse diet. In addition, increasing data suggests a critical role for a healthy gut microbiome in decreasing the risk of food allergy. Progress is being made in identifying recognizable risk factors associated with increased likelihood of developing food allergy, including atopic dermatitis, antibiotic exposure, C-section delivery and/or a gut microbiome dysbiosis.

The innovator(s) with the best novel methods, products, or technologies can receive grant funding from a total pool of $150,000, access to the global Johnson & Johnson Innovation – JLABS network, and mentorship from experts across the Johnson & Johnson Family of Companies.*

Apply at jji.jnj/food-allergy by February 18, 2022.

The QuickFire Challenges are managed by Johnson & Johnson Innovation, with the goal to help address today’s greatest health care challenges.

* Subject to the execution of the necessary documentation and (award) agreements.

This article was originally published here.